ABIGAIL GASU: Open Payments
NPI 1194120584 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 27 payments from 8 companies in 2025. Trend: 2023 $113 · 2024 $342 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $156 |
| Braeburn Inc. | 3 | $132 |
| Inspire Medical Systems, Inc. | 1 | $116 |
| Neurocrine BioSciences, Inc. | 1 | $103 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Novo Nordisk Inc | 1 | $19 |
Products named: VRAYLAR, BRIXADI, INSPIRE, INGREZZA, REXULTI, CAPLYTA, SPRAVATO, Wegovy.
Industry payments across OH — which companies pay providers there.
